9 Mar 2022 13:06
MD Medical Group Investments Plc (MDMG) MD Medical Group Investments Plc: MD Medical Group announces board of directors changes 09-March-2022 / 16:05 MSK Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
MD MEDICAL GROUP ANNOUNCES BOARD OF DIRECTORS CHANGES 9 March 2022 - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE, MOEX: MDMG), a leading Russian private healthcare provider, today announces changes in its Board of Directors.
Simon Rowlands decided to step down as a member of the Company's Board of Directors. The changes came into effect on March 9, 2022. Notes: 1. This announcement contains inside information.
*** For further information please contact:
About MD Medical Group MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 47 modern healthcare facilities, including 8 hospitals and 39 out-patient clinics in 25 of the Russian regions. In 2021, MDMG's revenue amounted to RUB 25.2 billion, up 32% y-o-y. The Company's GDRs are traded on London Stock Exchange (LSE: MDMG) and Moscow Exchange (MOEX: MDMG).
|
| ISIN: | US55279C2008 |
| Category Code: | BOA |
| TIDM: | MDMG |
| LEI Code: | 213800XKI6VHY4JBS612 |
| Sequence No.: | 148010 |
| EQS News ID: | 1298589 |
| End of Announcement | EQS News Service |
UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
MDMG.L (MDMG)